83 related articles for article (PubMed ID: 4741527)
1. Hypolipidemic action of a new aryloxy compound (S-8527) in rats.
Toki K; Nakamura Y; Agatsuma K; Nakatani H; Aono S
Atherosclerosis; 1973; 18(1):101-8. PubMed ID: 4741527
[No Abstract] [Full Text] [Related]
2. Morphological changes in the liver of rats treated with a new hypolipidemic agent, S-8527.
Sakamoto SI; Yamada K; Anzai T; Wada T
Atherosclerosis; 1973; 18(1):109-16. PubMed ID: 4741528
[No Abstract] [Full Text] [Related]
3. Effects of various hypolipidemic drugs on fatty acid composition of liver and serum lipids.
Maier R; Muller K
Adv Exp Med Biol; 1975; 63():349-57. PubMed ID: 1199873
[TBL] [Abstract][Full Text] [Related]
4. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
Kokatnur MG; Malcom GT
Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
[No Abstract] [Full Text] [Related]
5. Effects of S-8527 (1,1-bis(4'-(1'-carboxy-1'-methylpropoxy)phenyl) cyclohexane), a new hypolipidemic compound, on cholesterol and lipoprotein metabolism in rats.
Suzuki K
Biochem Pharmacol; 1976 Feb; 25(3):325-8. PubMed ID: 1267828
[No Abstract] [Full Text] [Related]
6. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
Tomita T; Takeshita R; Nagakura T; Hayashi E
Jpn J Pharmacol; 1973 Jun; 23(3):281-7. PubMed ID: 4541943
[No Abstract] [Full Text] [Related]
7. [Research regarding the action of a derivative of the clofibric acid series on lipid metabolism].
Filip M; Păduraru I; Hriscu A; Neacşu R; Dănilă G; Filip F
Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):341-5. PubMed ID: 3685700
[No Abstract] [Full Text] [Related]
8. The influence of 1,1-bis(4'-(1"-carboxy-1"-methylpropoxy)-phenyl)cyclohexane (a new aryloxy compound, S-8527) on cholesterol metabolism in rats.
Kritchevsky D; Tepper SA
Atherosclerosis; 1973; 18(1):93-9. PubMed ID: 4741537
[No Abstract] [Full Text] [Related]
9. Hypocholesterolaemia in the rat after p-chlorophenoxyisobutyric acid (CPIB) administration as a synthetic triglyceride, 1,3-dipalmitoyl 2(p-chlorophenoxyisobutyroyl)-rac-glycerol.
Owen JS; Billimoria JD
Clin Chim Acta; 1977 Sep; 79(2):349-56. PubMed ID: 890970
[TBL] [Abstract][Full Text] [Related]
10. Hypolipidemic effect of a new aryloxy compound, S-8527, in experimental animals.
Suzuki K; Aono S; Nakatani H
Jpn J Pharmacol; 1974 Jun; 24(3):407-14. PubMed ID: 4449146
[No Abstract] [Full Text] [Related]
11. Effects of S-8527 (1,1-bis4'-(1"-carboxy'1"-methylpropoxy)-phenyl)-cyclohexane), a new hypolipidemic compound, on triglyceride metablolism in rats.
Suzuki K
Biochem Pharmacol; 1975 Jun; 24(11-12):1203-7. PubMed ID: 237511
[No Abstract] [Full Text] [Related]
12. Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.
Fredj G; Clenet M; Cuchet P; Rousselet F; Rozé C
Digestion; 1979; 19(4):228-36. PubMed ID: 478204
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of adipocyte cholesterol during hypolipidemic drug treatment in cholesterol-fed rats.
Krause BR; Hartman AD
Biochim Biophys Acta; 1982 Dec; 713(3):485-93. PubMed ID: 7150624
[TBL] [Abstract][Full Text] [Related]
14. Effect of SaH 42-348, an analog of clofibrate, on lipid metabolism in rats.
Kritchevsky D; Tepper SA
Arzneimittelforschung; 1973 Jun; 23(6):858-9. PubMed ID: 4740771
[No Abstract] [Full Text] [Related]
15. Studies on hypolipidemic agents. III. Comparison of the hypolipidemic properties of 5-tridecylpyrazole-3-carboxylic acid and clofibrate.
Seki K; Fukuda M; Isegawa J; Ohki M
Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4103-9. PubMed ID: 6529804
[No Abstract] [Full Text] [Related]
16. Alterations in rat serum lipids and apolipoproteins following clofibrate treatment.
Dashti N; Ontko JA
Atherosclerosis; 1983 Dec; 49(3):255-66. PubMed ID: 6419747
[TBL] [Abstract][Full Text] [Related]
17. Regression of alcoholic fatty liver in the rat by medium-chain triglycerides.
Theuer RC; Martin WH; Friday TJ; Zoumas BL; Sarett HP
Am J Clin Nutr; 1972 Feb; 25(2):175-81. PubMed ID: 5009783
[No Abstract] [Full Text] [Related]
18. Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate.
Witiak DT; Newman HA; Poochikian GK; Fogt SW; Baldwin JR; Sober CL; Feller DR
J Med Chem; 1978 Aug; 21(8):833-7. PubMed ID: 99517
[TBL] [Abstract][Full Text] [Related]
19. Newer hypolipidemic agents.
Kritchevsky D
Fed Proc; 1971; 30(3):835-40. PubMed ID: 4996475
[No Abstract] [Full Text] [Related]
20. Effect of clofibrate on the handling of dietary and liver fat.
Westerfeld WW; Elwood JC; Richert DA
Biochem Pharmacol; 1972 Apr; 21(8):1117-25. PubMed ID: 5034197
[No Abstract] [Full Text] [Related]
[Next] [New Search]
